tiprankstipranks
Gyre Therapeutics (GYRE)
NASDAQ:GYRE

Gyre Therapeutics (GYRE) Revenue

827 Followers

Gyre Therapeutics Revenue

Gyre Therapeutics had a revenue of 37.20M in the quarter ending Dec 31, 2025, with 21.70%. This bring the company's revenue in the last twelve months to 116.59M, Decreased 8.69%. In the fiscal year ending Dec 31, 2025, Gyre Therapeutics had annual revenue of 116.59M with 10.24% growth.
Revenue (ttm)
116.59M
Revenue Growth
P/S Ratio
5.79
Revenue/Employee
$201,361
Employees
579
Market Cap
$674.81M

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2025
116.59M10.83M+10.24%
Dec 31, 2024
105.76M-7.69M-6.78%
Dec 31, 2023
113.45M11.16M+10.91%
Dec 31, 2022
102.29M94.95M+1,293.98%
Mar 31, 2022
7.34M-13.61M-64.97%
Dec 31, 2020
20.95M+∞%
Dec 31, 2019
-6.00K-100.00%
Dec 31, 2018
6.00K-1.01M-99.41%
Dec 31, 2017
1.02M